Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.26 Billion |
|---|---|
| Enterprise Value | $2.52 Billion |
| Earnings per Share | $-0.52 |
| Beta | 1.85 |
| Outstanding Shares | 266,200,000 |
| P/E Ratio | -3.52 |
|---|---|
| PEG | 8.78 |
| Price to Sales | - |
| Price to Book Ratio | -0.94 |
| Enterprise Value to Revenue | 11.55 |
| Enterprise Value to EBIT | -16.41 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | -1.1 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, a...